| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,704 |
3,508 |
$248K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,586 |
3,582 |
$235K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,149 |
3,834 |
$234K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,396 |
1,396 |
$127K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,264 |
1,172 |
$52K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,771 |
1,668 |
$12K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,102 |
1,065 |
$10K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
725 |
712 |
$8K |
| 99000 |
|
2,080 |
1,962 |
$7K |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
5,146 |
4,813 |
$4K |
| 99215 |
Prolong outpt/office vis |
14 |
12 |
$965.98 |
| 81002 |
|
386 |
373 |
$871.32 |
| 99058 |
|
13 |
12 |
$845.00 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
13 |
13 |
$377.65 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
280 |
272 |
$264.07 |
| 99051 |
|
980 |
968 |
$196.00 |
| 71046 |
Radiologic examination, chest; 2 views |
12 |
12 |
$193.59 |
| 81003 |
|
112 |
110 |
$176.58 |
| 99072 |
|
2,802 |
2,599 |
$129.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
12 |
12 |
$101.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
243 |
234 |
$97.93 |
| 81025 |
|
18 |
15 |
$78.43 |